Central nervous system metastases in women after multimodality therapy for high risk breast cancer

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.88, Iss.3, 2004-12, pp. : 273-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk factors for central nervous system metastasis in patients with metastatic breast cancer

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 155-161

Humana Press, Inc

Access to resources Recommend Favorite

Possible role of CXCR4-mediated chemotaxis in breast cancer patients with central nervous system metastases

By Altundag Kadri

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 317-317

Springer Publishing Company

Access to resources Recommend Favorite

Systemic high-dose intravenous methotrexate for central nervous system metastases

By Lassman Andrew Abrey Lauren Shah Gaurav Panageas Katherine Begemann Martin Malkin Mark Raizer Jeffrey

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

Systemic high-dose intravenous methotrexate for central nervous system metastases

By Lassman Andrew Abrey Lauren Shah Gaurav Panageas Katherine Begemann Martin Malkin Mark Raizer Jeffrey

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 261-261

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

By Ryberg Marianne

Breast Cancer Research and Treatment, Vol. 91, Iss. 3, 2005-06 ,pp. : 217-225

Springer Publishing Company

Access to resources Recommend Favorite